Skip to main content

Department of Medicine

Getting the goods on obesity

Nov. 19, 2019—Obesity and two post-operative complications linked with it have associated genetic variants in common, suggesting that obesity may be the culprit.

Read more


RSV transmission in the Middle East

Nov. 14, 2019—Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design.

Read more


Endotoxin shock protector

Nov. 5, 2019—A novel tool developed by Vanderbilt scientists protects animals from endotoxin shock and can be used for mechanistic analyses of inflammation due to microbial and other insults.

Read more


Acute kidney injury recovery time impacts future risk

Oct. 31, 2019—Interventions that impact the timing of recovery following acute injury may improve future outcomes for patients.

Read more


Department of Medicine mini-research retreat set for Nov. 1

Oct. 10, 2019—The Department of Medicine will host a mini-retreat exploring “The Janus Face of Immunotherapy: The Good, the Bad, the Weird” on Friday, Nov. 1, led by Dr. Javid Moslehi and Dr. Doug Johnson. The event will be from 11:30 a.m. to 4:30 p.m. in Light Hall, Room 208.

Read more


A new regulator of B cell development

Oct. 8, 2019—New findings establish a role for the pro-inflammatory molecule IL-33 in the early development of antibody-producing B cells.

Read more


Study: personalized decision support affects intensive care

Oct. 3, 2019—For patients in pediatric intensive care who are at high risk for acute kidney injury (AKI), giving clinicians automated decision support during the electronic order entry process increased the rate of blood testing for AKI by 9%.

Read more


A step toward gastric cancer

Oct. 3, 2019—New research findings provide insight into the detrimental events that develop in response to H. pylori infection.

Read more


Study shines light on architecture of kidney disease

Sep. 25, 2019—A study of 280,000 U.S. veterans, including 56,000 African Americans, has identified in greater detail than ever before the genetic architecture of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues.

Read more


Diabetes drug study explores cardiovascular risks for patients with kidney disease

Sep. 25, 2019—An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

Read more


Treating C. diff: new purpose for an old drug?

Sep. 24, 2019—An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice.

Read more


Potential prostate cancer biomarkers

Sep. 19, 2019—An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk.

Read more


VIEW MORE EVENTS >